An effective video on lymphoma basics succeeds because it's soooo boring

The video below is DRY.

It is almost 100% free of charisma.

It reminds me of a George Carlin line about something so boring it's like watching flies f*ck.

BUT …

But if you're entirely new to lymphoma, it's an awesome video to watch. Chiefly because the doctor, Maria Baer MD, and the interviewer, Ellen Beth Levitt, deliver the basics of lymphoma at an andantino tempo; measured perfectly for neophytes, careful not to get into the peculiars of this broad disease and confuse the message, careful not to inject too much personality into the discussion and distract the viewer.

If you or a loved one is recently diagnosed and you're wondering, "What is lymphoma?" and you prefer videos without any frills, this a good place to start.

Dr. Baer is an odd bird who reminds me of a Japanese student I once had while teaching English who began every sentence with the word, "So." But she's very intelligent and she's a much better communicator than she seems she's going to be if you watch part 1 about Leukemia (she begins that clip frozen to the camera).

Note: This video opens with a brief word on Multiple Myeloma. Unless you're here to hear about that, just be patient. The basics of lymphoma will begin soon.

Dr. Maria Baer is currently the head of the Hematologic Malignancies Program at the University of Maryland Marlene and Stewart Greenebaum Cancer Center.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap